Evaluation of Effectiveness of Long-Term Therapy with Russian Rituximab Biosimilar (Acellbia) in Sjogren's Disease in Real Clinical Practice.

Chaltsev BD, Vasilyev VI, Torgashina AV, Khvan YI, Rodionova EB, Selifanova EI, Safonova TN, Semenova LA, Burtseva MV, Glukhova SI

Open source

DOI: 10.1134/s1607672925700255
Published: 2026 Feb
Container: Doklady. Biochemistry and biophysics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1134/s1607672925700255,
  title = {Evaluation of Effectiveness of Long-Term Therapy with Russian Rituximab Biosimilar (Acellbia) in Sjogren's Disease in Real Clinical Practice.},
  author = {Chaltsev BD and Vasilyev VI and Torgashina AV and Khvan YI and Rodionova EB and Selifanova EI and Safonova TN and Semenova LA and Burtseva MV and Glukhova SI},
  year = {2026},
  journal = {Doklady. Biochemistry and biophysics},
  doi = {10.1134/s1607672925700255},
  url = {https://doi.org/10.1134/s1607672925700255}
}

RIS

TY  - JOUR
TI  - Evaluation of Effectiveness of Long-Term Therapy with Russian Rituximab Biosimilar (Acellbia) in Sjogren's Disease in Real Clinical Practice.
AU  - Chaltsev BD
AU  - Vasilyev VI
AU  - Torgashina AV
AU  - Khvan YI
AU  - Rodionova EB
AU  - Selifanova EI
AU  - Safonova TN
AU  - Semenova LA
AU  - Burtseva MV
AU  - Glukhova SI
PY  - 2026
JO  - Doklady. Biochemistry and biophysics
DO  - 10.1134/s1607672925700255
UR  - https://doi.org/10.1134/s1607672925700255
ER  -

APA

BD, C., VI, V., AV, T., YI, K., EB, R., EI, S., TN, S., LA, S., MV, B., & SI, G. (2026). Evaluation of Effectiveness of Long-Term Therapy with Russian Rituximab Biosimilar (Acellbia) in Sjogren's Disease in Real Clinical Practice.. Doklady. Biochemistry and biophysics. https://doi.org/10.1134/s1607672925700255

Source records

pubmed · retrieved 2026-09-26T05:45:18.851Z